NASDAQ

SpyGlass Pharma, Inc. (SGP)

♥ 551 Thanks from members

Live price chart, market sentiment, and community perspectives for SpyGlass Pharma, Inc. (NASDAQ: SGP).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Biotechnology and Medical DevicesFounder: SpyGlass Pharma TeamLeadership: Jim Mazzo (Executive Chairman)Leadership: Patrick Melia (CEO)Holder: Venture Capital FirmsHolder: Life Science InvestorsSustained-Release Intraocular Lens PlatformOphthalmology Therapeutics#SGP#SpyGlass Pharma#Ophthalmic Drugs#Drug Delivery#NASDAQ